Brief: Tianjin Development Says Tianjin Lisheng Pharmaceutical's Qtrly Net Profit Attributable Rmb44.4 Mln
24/04/2019 05:08
April 24 (Reuters) - Tianjin Development Holdings Ltd
0882.HK :
* TIANJIN LISHENG PHARMACEUTICAL'S QTRLY TOTAL OPERATING
INCOME
RMB434.5 MILLION VERSUS RMB393.8 MILLION
* TIANJIN LISHENG PHARMACEUTICAL QTRLY NET PROFIT
ATTRIBUTABLE
RMB44.4 MILLION VERSUS RMB40.9 MILLION
Source text for Eikon: ID:nHKS1Bnrft
Further company coverage: 0882.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tianjin Development Holdings
See all newsHong Kong's Tianjin Development HY revenue on lower pharmaceutical, utilities sales
Brief: Tianjin Development Says Teng Fei Resigns As Chairman And Executive Director
Brief: Tianjin Development Says H1 2026 Net Profit Seen At RMB 73-83 Million For Tianjin Lisheng Pharmaceutical
Brief: Tianjin Development Says Lisheng Pharmaceutical Subscribes To Investment Products Totaling RMB180 Million
Brief: Tianjin Development Says Tianjin Lisheng Pharmaceutical QTRLY Operating Income RMB 332.28 Mln